查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198773

玻璃体切除术设备市场-增长、趋势、COVID-19 影响和预测 (2023-2028)

Vitrectomy Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，玻璃体切除术市场的复合年增长率预计为 7.4%。

COVID-19 大流行最初对玻璃体切除术市场产生了重大影响。 为了应对这一流行病，世界各地的医院减少了门诊部的现场护理，并最大限度地利用一线资源进行流行病管理。 在 JAMA Ophthalmol 2021 上发表的一项针对 17 个中心的 526,536 家研究发现，从 2020 年 3 月中旬到至少 5 月，激光、冷冻疗法、视网膜脱离修復和其他形式的玻璃体切除术的使用显着减少。没错。 此外，由于漫长的等待时间和患者对前往医疗机构的恐惧，就患者数量和手术而言，眼科是受影响最严重的专业之一。 然而，美国眼科学会 (AAO) 指出，在 COVID-19 流行期间应继续进行紧急视网膜玻璃体切除术。 因此，COVID-19 爆发对其前身的市场增长产生了负面影响。 然而，随着全球玻璃体切除术病例数恢復正常，市场受到关注。

此外，糖尿病性视网膜病变和视网膜脱离患病率的增加以及玻璃体切除术的技术进步是推动所研究市场增长的主要因素。 根据国际防盲协会 (IAPB) 的数据，全球约有 9300 万人患有糖尿病性视网膜病变。 大约三分之一的糖尿病患者也有一定程度的糖尿病视网膜病变，预计每 10 人中就有 1 人会发展为威胁视力的疾病。 预计这些因素将增加对玻璃体切除术器械的需求，并促进所研究市场的增长。

根据 IDF 的数据，到 2021 年，大约 5.37 亿 20-79 岁的成年人将患有糖尿病。 此外，糖尿病患者总数预计到 2030 年将增加到 6.43 亿，到 2045 年将增加到 7.83 亿。 此外，隶属于 IAPB 的视力丧失专家组估计，到 2020 年，全球将有 100 万人因糖尿病视网膜病变而失明，超过 300 万人将出现中度至重度视力障碍。 此外，增加对糖尿病视网膜病变的筛查和增加对糖尿病视网膜病变认识的活动也促进了市场的增长。 例如，2022 年 11 月，全印度眼科学会 (AIOS) 和印度玻璃体视网膜学会 (VRSI) 组织了一场步行马拉松，以纪念世界糖尿病日并提高人们对糖尿病性视网膜病变的认识。 因此，糖尿病视网膜病变和视网膜脱离患病率的增加有望加速全球玻璃体切除术市场的发展，并有望继续增长，从而在预测期内推动研究市场的增长。

因此，由于上述因素，预计所研究的市场在分析期内将增长。 然而，患者不适和与玻璃体切除术相关的风险可能会阻碍市场增长。

玻璃体切割市场趋势

玻璃体切割系统部分预计在预测期内实现增长

玻璃体切除术是一个快速发展的领域，越来越复杂的显微外科器械使先进的手术成为可能。 近年来，技术进步使巩膜切开术变得更小，减少了手术创伤并提高了玻璃体切除术的效率。 因此，先进玻璃体切除术系统的优势有望增加医生对这些产品的需求，最终推动市场增长。

近年来，玻璃体切割系统的多项技术进步进一步推动了市场增长。 例如，切割率超过每分钟 10,000 次 (CPM) 的高速玻璃体切除术系统最近受到欢迎。 高切割率导致视网膜牵引力下降。 此外，市场巨头不断推出的产品对该细分市场的增长产生了积极影响。 例如，2022 年 3 月，DORC International 推出了具有视网膜、白内障和联合手术能力的集成系统“EVA NEXUS”。 该产品的推出有望显着增强公司的产品组合。 此外，2022 年 7 月，Bosch Health Companies 启动了升级，以提高其 Stellaris Elite 视力增强系统的效率。 此升级包括将最大真空设置从 600 增加到 660mmHg，以及用于套管针/插管系统的增强型可拆卸阀盖。 因此，由于上述因素，预计玻璃体切除术系统部分在预测期内将出现显着增长。

北美有望主导玻璃体切割市场

北美最有望主导市场。 此外，美国熟练眼科医生的可用性和日益老龄化的人口也是促进北美市场增长的主要因素之一。

主要产品的发布和批准、市场参与者的高度集中以及製造商在美国的存在是推动该国玻璃体切除术市场增长的一些因素。 例如，2022 年 4 月，Carl Zeiss AG 获得了 FDA 对 QUATERA 700 系统的批准。 蔡司 QUATERA 700 旨在提高外科医生从诊所到手术室的工作流程效率。 这些持续的产品发布和批准预计将推动该地区的市场增长。

因此，由于上述因素，北美地区的市场有望增长。

玻璃体切除术设备市场竞争对手分析

由于全球和区域运营的公司数量有限，玻璃体切除术市场正在经历一些整合。 竞争格局包括一些拥有大量市场份额的国际参与者，如爱尔康、博士伦健康公司、BVI、DORC Holding B.V.、强生、Geuder AG、NIDEK CO.、Carl Zeiss Meditec AG、Hoya Surgical Optics 和 Topcon Corporation . 包括本地公司和公司的分析。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 糖尿病性视网膜病变和视网膜脱离的患病率增加
    • 玻璃体切除术的技术进步
  • 市场製约因素
    • 玻璃体切除术相关的患者不适和风险
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品类型
    • 玻璃体切割系统
    • 照明设备
    • 注入装置
    • 乐器
    • 其他产品类型（可视化设备、光凝设备、冷冻治疗设备）
  • 通过申请
    • 糖尿病视网膜病变
    • 视网膜脱离
    • 黄斑裂孔
    • 玻璃体积血
    • 其他用途（玻璃体飞蚊症、黄斑水肿）
  • 最终用户
    • 医院
    • 眼科诊所
    • 门诊手术中心
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Alcon
    • Bausch Health Companies Inc.
    • BVI
    • DORC Holding B.V.
    • Johnson & Johnson
    • Geuder AG
    • NIDEK CO.
    • Carl Zeiss Meditec AG
    • Hoya Surgical Optics
    • Topcon Corporation

第7章 市场机会今后动向

简介目录
Product Code: 92781

The Vitrectomy Devices Market is expected to register a CAGR of 7.4% over the forecast period.

The COVID-19 pandemic initially had a significant impact on the market for vitrectomy devices. As a safety response to the pandemic, hospitals worldwide reduced in-person checkups in outpatient departments to maximize the use of resources on the front to manage the pandemic. According to a cross-sectional study of 526,536 procedures across 17 institutions published in JAMA Ophthalmol 2021, there was a significant decrease in the use of lasers and cryotherapy, retinal detachment repairs, and other vitrectomies from mid-March 2020 to at least May 2020. Moreover, ophthalmology has been one of the most severely impacted specialties regarding patient numbers and surgeries, owing to a long waiting time and a fear among patients visiting medical facilities. However, the American Academy of Ophthalmology (AAO) indicated that urgent or emergent vitreoretinal surgical procedures should continue during the COVID-19 pandemic. Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, the market gained traction due to the normalcy in the number of vitrectomy surgeries globally.

Further, the increasing prevalence of diabetic retinopathy and retinal detachment and technological advances in vitrectomy procedures are among the major factors driving the growth of the market studied. According to the International Agency for the Prevention of Blindness (IAPB), approximately 93 million people globally have diabetic retinopathy. In addition, about 1 in 3 people with diabetes have some degree of diabetic retinopathy, and 1 in 10 are anticipated to develop a vision-threatening form of the disease. Such factors will likely boost the demand for vitrectomy devices, thereby contributing to the growth of the market studied.

According to the IDF, in 2021, approximately 537 million adults (20-79 years of age) were living with diabetes. In addition, it is anticipated that the total number of people living with diabetes will rise to 643 million by 2030 and 783 million by 2045. Furthermore, the Vision Loss Expert Group, a part of the IAPB Organization, estimated that in 2020, 1 million people were blind globally due to diabetic retinopathy, and over 3 million had moderate-to-severe vision impairment. Moreover, increasing screening for diabetic retinopathy and an increasing number of campaigns raising awareness of diabetic retinopathy is also driving the market growth. For instance, in November 2022, the All India Ophthalmological Society (AIOS) and Vitreo-Retinal Society of India (VRSI) commemorated World Diabetes Day by organizing a walking marathon to raise awareness for diabetic retinopathy. Thus, the increasing prevalence of diabetic retinopathy and retinal detachment is poised to accelerate the vitrectomy devices market globally and is expected to increase in the future, thereby driving the growth of the studied market over the forecast period.

Therefore, owing to the factors mentioned above, it is anticipated that the market studied will witness growth over the analysis period. However, patient discomfort and risks associated with the vitrectomy procedure are likely to impede the market's growth.

Vitrectomy Devices Market Trends

Vitrectomy Systems Segment is Expected to Witness Growth Over the Forecast Period

Vitrectomy is a rapidly advancing field, with increasingly refined microsurgical instrumentation allowing for advanced techniques. In recent years, technological advances have further led to the miniaturization of the scleral incision to mitigate the trauma of the surgical procedure and increase the efficiency of the vitrectomy. Hence, owing to the advantages of advancing vitrectomy systems, the demand for these products is likely to increase among physicians, ultimately driving the market's growth.

In recent years, several technological advancements in vitrectomy systems are further driving the market growth. For instance, high-speed vitrectomy systems with a cut rate of above 10,000 cuts/minute (CPM) have recently become popular. The higher cut rates lead to a decrease in retinal traction. Furthermore, continuous product launches by major players in the market are positively affecting the segment's growth. For instance, in March 2022, DORC International launched EVA NEXUS, an integrated system with retina, cataract, and combined surgery capabilities. This product launch is anticipated to enhance its product portfolio significantly. Further, in July 2022, Bausch Health Companies, Inc. launched efficiency-enhancing upgrades for the Stellaris Elite vision enhancement system. The upgrades include increasing the maximum vacuum setting from 600 to 660 mmHg and enhancing the removable valve caps in the trocar/cannula system. Therefore, the vitrectomy systems segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America is Expected to Dominate the Vitrectomy Devices Market

North America is expected to dominate the market owing to factors such as the easy availability of technologically advanced products, the growing prevalence of eye-related disorders, high awareness of diabetic retinopathy, and a significant uptake in medical screening in the region. In addition, the availability of skilled ophthalmologists and the increasing geriatric population in the United States are among the key factors contributing to the growth of the market studied in North America.

Key product launches and approvals, the high concentration of market players, and the manufacturer's presence in the United States are some of the factors driving the growth of the vitrectomy devices market in the country. For instance, in April 2022, Carl Zeiss AG received FDA approval for the QUATERA 700 system. The ZEISS QUATERA 700 is designed to increase a surgeon's workflow efficiency from the clinic to the operating room. These continuous product launches and approvals in the region are anticipated to drive market growth in the country.

Therefore, owing to the factors mentioned above, the growth of the studied market is anticipated in the North American region.

Vitrectomy Devices Market Competitor Analysis

The vitrectomy devices market is slightly consolidated due to the presence of limited companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market shares, including Alcon, Bausch Health Companies Inc., BVI, DORC Holding B.V., Johnson & Johnson, Geuder AG, NIDEK CO., Carl Zeiss Meditec AG, Hoya Surgical Optics, and Topcon Corporation, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Diabetic Retinopathy and Retinal Detachment
    • 4.2.2 Technological Advances in Vitrectomy Procedures
  • 4.3 Market Restraints
    • 4.3.1 Patient Discomfort and Risks Associated with the Vitrectomy Procedure
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Vitrectomy System
    • 5.1.2 Illumination Devices
    • 5.1.3 Infusion Devices
    • 5.1.4 Instruments
    • 5.1.5 Other Product Types (Visualization Devices, Photocoagulation Devices, Cryotherapy Devices)
  • 5.2 By Application
    • 5.2.1 Diabetic Retinopathy
    • 5.2.2 Retinal Detachment
    • 5.2.3 Macular Hole
    • 5.2.4 Vitreous Hemorrhage
    • 5.2.5 Other Applications (Vitreous floaters, Macular Pucker)
  • 5.3 By End-Users
    • 5.3.1 Hospitals
    • 5.3.2 Ophthalmology Clinics
    • 5.3.3 Ambulatory Surgical Centers
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon
    • 6.1.2 Bausch Health Companies Inc.
    • 6.1.3 BVI
    • 6.1.4 DORC Holding B.V.
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Geuder AG
    • 6.1.7 NIDEK CO.
    • 6.1.8 Carl Zeiss Meditec AG
    • 6.1.9 Hoya Surgical Optics
    • 6.1.10 Topcon Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS